504 related articles for article (PubMed ID: 27476087)
1. Causes of Death and Influencing Factors in Patients with Atrial Fibrillation.
Fauchier L; Villejoubert O; Clementy N; Bernard A; Pierre B; Angoulvant D; Ivanes F; Babuty D; Lip GY
Am J Med; 2016 Dec; 129(12):1278-1287. PubMed ID: 27476087
[TBL] [Abstract][Full Text] [Related]
2. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
[TBL] [Abstract][Full Text] [Related]
3. Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation.
Sharma A; Hijazi Z; Andersson U; Al-Khatib SM; Lopes RD; Alexander JH; Held C; Hylek EM; Leonardi S; Hanna M; Ezekowitz JA; Siegbahn A; Granger CB; Wallentin L
Circulation; 2018 Oct; 138(16):1666-1676. PubMed ID: 29871978
[TBL] [Abstract][Full Text] [Related]
4. Prior history of falls and risk of outcomes in atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
Banerjee A; Clementy N; Haguenoer K; Fauchier L; Lip GY
Am J Med; 2014 Oct; 127(10):972-8. PubMed ID: 24929021
[TBL] [Abstract][Full Text] [Related]
5. Better clinical outcome with direct oral anticoagulants in hospitalized heart failure patients with atrial fibrillation.
Yoshihisa A; Sato Y; Sato T; Suzuki S; Oikawa M; Takeishi Y
BMC Cardiovasc Disord; 2018 Jan; 18(1):11. PubMed ID: 29368593
[TBL] [Abstract][Full Text] [Related]
6. Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study.
Marijon E; Le Heuzey JY; Connolly S; Yang S; Pogue J; Brueckmann M; Eikelboom J; Themeles E; Ezekowitz M; Wallentin L; Yusuf S;
Circulation; 2013 Nov; 128(20):2192-201. PubMed ID: 24016454
[TBL] [Abstract][Full Text] [Related]
7. Causes of Death in Anticoagulated Patients With Atrial Fibrillation.
Gómez-Outes A; Lagunar-Ruíz J; Terleira-Fernández AI; Calvo-Rojas G; Suárez-Gea ML; Vargas-Castrillón E
J Am Coll Cardiol; 2016 Dec; 68(23):2508-2521. PubMed ID: 27931607
[TBL] [Abstract][Full Text] [Related]
8. Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients.
Rivera-Caravaca JM; Roldán V; Esteve-Pastor MA; Valdés M; Vicente V; Lip GYH; Marín F
Thromb Haemost; 2017 Jun; 117(7):1448-1454. PubMed ID: 28331926
[TBL] [Abstract][Full Text] [Related]
9. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
[TBL] [Abstract][Full Text] [Related]
10. High overall cardiovascular risk and mortality in patients with atrial fibrillation and diabetes: A nationwide report.
Karayiannides S; Lundman P; Friberg L; Norhammar A
Diab Vasc Dis Res; 2018 Jan; 15(1):31-38. PubMed ID: 29052435
[TBL] [Abstract][Full Text] [Related]
11. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
[TBL] [Abstract][Full Text] [Related]
12. Causes of death in Japanese patients with atrial fibrillation: The Fushimi Atrial Fibrillation Registry.
An Y; Ogawa H; Yamashita Y; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Lip GYH; Akao M
Eur Heart J Qual Care Clin Outcomes; 2019 Jan; 5(1):35-42. PubMed ID: 30020445
[TBL] [Abstract][Full Text] [Related]
13. [Causes of death and influencing factors of atrial fibrillation patients undergoing anticoagulation therapy].
Hua C; Jiang C; He L; Jia ZX; Lyu WH; Tang RB; Sang CH; Long DY; Dong JZ; Ma CS; Du X
Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Apr; 49(4):353-359. PubMed ID: 33874685
[No Abstract] [Full Text] [Related]
14. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D;
Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522
[TBL] [Abstract][Full Text] [Related]
15. Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation: AMADEUS Trial.
Senoo K; Lip GY; Lane DA; Büller HR; Kotecha D
Stroke; 2015 Sep; 46(9):2523-8. PubMed ID: 26205373
[TBL] [Abstract][Full Text] [Related]
16. Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands.
Vermond RA; Geelhoed B; Verweij N; Tieleman RG; Van der Harst P; Hillege HL; Van Gilst WH; Van Gelder IC; Rienstra M
J Am Coll Cardiol; 2015 Sep; 66(9):1000-7. PubMed ID: 26314526
[TBL] [Abstract][Full Text] [Related]
17. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients.
Genovesi S; Vincenti A; Rossi E; Pogliani D; Acquistapace I; Stella A; Valsecchi MG
Am J Kidney Dis; 2008 Feb; 51(2):255-62. PubMed ID: 18215703
[TBL] [Abstract][Full Text] [Related]
18. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
[TBL] [Abstract][Full Text] [Related]
19. Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation.
Shen JI; Montez-Rath ME; Lenihan CR; Turakhia MP; Chang TI; Winkelmayer WC
Am J Kidney Dis; 2015 Oct; 66(4):677-88. PubMed ID: 26162653
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]